Literature DB >> 8385909

Induction of bilateral retinal necrosis in mice by unilateral intracameral inoculation of a glycoprotein-C deficient clinical isolate of herpes simplex virus type 1.

Y Liu1, Y Sakai, H Minagawa, Y Toh, T Ishibashi, H Inomata, R Mori.   

Abstract

Herpes simplex virus can cause acute retinal necrosis, a blinding retinal disease in man. A unilateral intracameral inoculation of herpes simplex virus type 1 (HSV-1) in mice induces retinal necrosis primarily in the contralateral eye and provides an experimental model for the disease. Previous studies suggested that a major envelope glycoprotein of HSV-1, glycoprotein C (gC), is required for retinal necrosis. We studied HSV-1 strain TN-1, a gC-deficient clinical isolated from a lesion of herpetic keratitis, for its pathogenicity in mice with an intracameral inoculation of the virus and found that TN-1 could induce severe necrotizing retinitis in both inoculated and uninoculated eyes of BALB/c mice. Inoculation with a lower dose of TN-1 resulted in a unilateral necrotizing retinitis in the uninoculated eyes. Tissue virus titration of infected mice killed at various times after inoculation detected an infectious virus in various organs including the eyeballs, trigeminal ganglia, brain and adrenal glands. Anterior chamber-associated immune deviation (ACAID) was observed in TN-1-inoculated mice as well as in mice inoculated with gC-positive laboratory strain KOS 7 days postinoculation. Our findings suggested that gC of HSV-1 is not necessary for either the induction of retinal necrosis, neural spread of the virus, or ACAID.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385909     DOI: 10.1007/bf01316888

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

1.  Two waves of virus following anterior chamber inoculation of HSV-1.

Authors:  S S Atherton; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-03       Impact factor: 4.799

2.  Difference in age distribution of antibody to herpes simplex virus in Fukuoka, Manila and Busan.

Authors:  Y Hayashi; M Nagata; H Yoshizumi; R Mori; C V Navarro; H D Yang
Journal:  Jpn J Med Sci Biol       Date:  1984-02

3.  Retinitis and deviant immune responses following intravitreal inoculation of HSV-1.

Authors:  S S Atherton; G A Pesicka; J W Streilein
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-05       Impact factor: 4.799

4.  Herpes simplex virus type-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice.

Authors:  R Hemady; E M Opremcak; M Zaltas; A Berger; C S Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-08       Impact factor: 4.799

5.  Isolation of a herpes simplex virus type 2 that is retinovirulent in mice.

Authors:  S B Mahjoub; J P Ganley; R P Misra; M P Langford
Journal:  Curr Eye Res       Date:  1989-07       Impact factor: 2.424

6.  Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes.

Authors:  J U Igietseme; J W Streilein; F Miranda; S J Feinerman; S S Atherton
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.

Authors:  Y Hidaka; Y Sakai; Y Toh; R Mori
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

8.  Molecular characterization of naturally occurring glycoprotein C-negative herpes simplex virus type 1.

Authors:  Y Toh; S Tanaka; Y Liu; Y Hidaka; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones.

Authors:  R M Johnson; D W Lancki; F W Fitch; P G Spear
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

10.  Ocular lesions in mice following intracerebral injection of herpes simplex virus type I.

Authors:  R L Peiffer; C D Dekker; F L Siegel
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-08       Impact factor: 4.799

View more
  3 in total

1.  Necrotizing chorioretinitis in mice inoculated with herpes simplex virus type 1 with or without glycoprotein C: anterior chamber-associated immune deviation does not persist.

Authors:  Y Liu; H Minagawa; Y Toh; Y Sakai; T Ishibashi; H Inomata; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Molecular characterization of naturally occurring glycoprotein C-negative herpes simplex virus type 1.

Authors:  Y Toh; S Tanaka; Y Liu; Y Hidaka; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Widely Used Herpes Simplex Virus 1 ICP0 Deletion Mutant Strain dl1403 and Its Derivative Viruses Do Not Express Glycoprotein C Due to a Secondary Mutation in the gC Gene.

Authors:  Cristina W Cunha; Kathryne E Taylor; Suzanne M Pritchard; Mark G Delboy; Tri Komala Sari; Hector C Aguilar; Karen L Mossman; Anthony V Nicola
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.